Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial.
Tsuji D, Kim YI, Taku K, Nakagaki S, Ikematsu Y, Tsubota H, Maeda M, Hashimoto N, Kimura M, Daimon T. Tsuji D, et al. Among authors: nakagaki s. Support Care Cancer. 2012 May;20(5):1057-64. doi: 10.1007/s00520-011-1185-x. Epub 2011 May 18. Support Care Cancer. 2012. PMID: 21590327 Clinical Trial.
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer.
Miyagi T, Tsuji D, Kawasakai Y, Ishikawa H, Tanaka R, Nakao M, Nakagaki S, Hayashi T, Ayuhara H, Harada T, Tamaki S, Maeda A, Ohashi Y, Arakawa Y, Fujita Y, Yamamoto K, Miyamoto Y, Yano T, Itoh K. Miyagi T, et al. Among authors: nakagaki s. Eur J Clin Pharmacol. 2023 Mar;79(3):407-414. doi: 10.1007/s00228-023-03451-1. Epub 2023 Jan 16. Eur J Clin Pharmacol. 2023. PMID: 36645467
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I.
Tsuji D, Nakagaki S, Yonezawa I, Suzuki K, Yokokawa T, Kawasaki Y, Yamaguchi T, Kawaguchi T, Hatori M, Matsumoto T, Sakata Y, Yamamoto K, Nishimura T, Kogure Y, Hayashi T, Osawa M, Itoh K, Watanabe M. Tsuji D, et al. Among authors: nakagaki s. Invest New Drugs. 2024 Feb;42(1):44-52. doi: 10.1007/s10637-023-01414-y. Epub 2023 Dec 6. Invest New Drugs. 2024. PMID: 38055127 Clinical Trial.
Comparison of the Photodynamic Action of Porphyrin, Chlorin, and Isobacteriochlorin Derivatives toward a Melanotic Cell Line.
Castro KADF, Ramos L, Mesquita M, Biazzotto JC, Moura NMM, Mendes RF, Almeida Paz FA, Tomé AC, Cavaleiro JAS, Simões MMQ, Faustino MAF, Jager AV, Nakagaki S, P M S Neves MG, da Silva RS. Castro KADF, et al. Among authors: nakagaki s. ACS Appl Bio Mater. 2021 Jun 21;4(6):4925-4935. doi: 10.1021/acsabm.1c00218. Epub 2021 May 19. ACS Appl Bio Mater. 2021. PMID: 35007041
74 results